Pfizer could move outside manufacturing to the US, says CEO

(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in the U.S., if required, as the Donald Trump administration threatens numerous tariffs on imported goods. "We have all the capabilities here and the manufacturing sites are operating in good capacity right now. If something happens, we will try to mitigate by transferring